A new diagnostic test can tell whether beta-interferon -- the major treatment for multiple sclerosis -- will work for multiple sclerosis patients even before therapy begins. A team led by Larry Steinman, a neurologist at Stanford University, found the efficacy of the $25,000 per year drug depends on which type of immune cell is involved in the disease. The research appears on-line at www.nature.com/naturemedicine -- Axtell et al. Nature Medicine, 28 March 2010. DOI: 10.1038/nm.2110
Questions about Splitting Sclerosis: by Nature Video
Want more info about Splitting Sclerosis: by Nature Video?
Get free advice from education experts and Noodle community members.